This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Duke Translational Medicine Institute | |
|---|---|
| Name | Duke Translational Medicine Institute |
| Established | 2006 |
| Type | Research institute |
| Parent | Duke University |
| Location | Durham, North Carolina |
Duke Translational Medicine Institute is a biomedical research center located at Duke University that focuses on translating laboratory discoveries into clinical applications. The institute engages with departments across Duke University, collaborates with hospitals such as Duke University Hospital, and partners with agencies including the National Institutes of Health, Food and Drug Administration, and private entities like Pfizer and Johnson & Johnson.
The institute was founded in 2006 amid broader translational efforts championed by leaders from Duke University School of Medicine, administrators associated with Duke University Health System, and supporters from foundations such as the Gates Foundation, reflecting trends seen at counterparts like Massachusetts General Hospital, Johns Hopkins Hospital, and Mayo Clinic. Early initiatives drew on programs modeled after the Clinical and Translational Science Awards administered by the National Center for Advancing Translational Sciences, with guidance from figures linked to National Institutes of Health directors and policy advisors from the Institute of Medicine. Over time, the institute expanded collaborations with academic centers including Harvard Medical School, Stanford University School of Medicine, and University of California, San Francisco while participating in consortia that featured members from Columbia University Irving Medical Center, Yale School of Medicine, and University of Pennsylvania Perelman School of Medicine.
The institute states objectives to accelerate bench-to-bedside research by integrating investigators from Duke University School of Medicine, clinicians from Duke University Hospital, and methodologists from Duke Clinical Research Institute. Its mission aligns with federal priorities articulated by the National Institutes of Health, the Department of Health and Human Services, and international frameworks promoted by organizations like the World Health Organization. Strategic goals include advancing clinical trials overseen by regulatory bodies such as the Food and Drug Administration, supporting translational pipelines similar to initiatives at Scripps Research, and fostering partnerships with industry leaders including GlaxoSmithKline and Novartis.
The institute is organized with leadership drawn from faculty in departments such as Department of Medicine (Duke), Department of Pharmacology (Duke), and Department of Biostatistics and Bioinformatics (Duke), and it coordinates with administrative offices like Duke Office of Research. Governance includes advisory committees composed of representatives from National Institutes of Health, investment groups like Kleiner Perkins, and clinical partners from Duke Health System. Operational units mirror those at centers such as Broad Institute and Gladstone Institutes, featuring cores for biostatistics modeled on Biostatistics Department (Columbia University), informatics similar to Stanford Center for Biomedical Informatics Research, and regulatory affairs paralleling staff at University of California, Los Angeles School of Medicine.
Research spans translational domains including oncology collaborations with teams from Duke Cancer Institute and basic science interactions with labs influenced by work at Cold Spring Harbor Laboratory, immunology projects linked to groups at La Jolla Institute for Immunology, and cardiovascular studies coordinated with investigators from Cleveland Clinic. Programs include clinical trial support akin to the Duke Clinical Research Institute model, precision medicine projects inspired by the All of Us Research Program, and data science efforts comparable to the Human Genome Project and ENCODE Project. The institute also participates in multicenter consortia with partners such as Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Fred Hutchinson Cancer Research Center.
Clinical collaborations extend to specialty centers including Duke Eye Center, Duke Center for Autism and Brain Development, and community partners tied to public health departments like the North Carolina Department of Health and Human Services. Translational projects have included trials involving therapeutics developed by companies like Amgen, diagnostics piloted with collaborators from GE Healthcare, and implementation science initiatives resonant with efforts at Vanderbilt University Medical Center and University of Michigan Health System. The institute engages in multicenter randomized trials overseen by networks similar to ClinicalTrials.gov registrants and coordinates IRB processes with entities resembling the Duke Health Institutional Review Board.
Training programs connect trainees from Duke University School of Medicine, graduate students enrolled in Duke Graduate School, and postdoctoral fellows who previously trained at institutions like Broad Institute and Salk Institute. Curricula include coursework modeled after programs at Harvard T.H. Chan School of Public Health, mentorship structures akin to the Howard Hughes Medical Institute fellowships, and certificate programs comparable to those at Johns Hopkins Bloomberg School of Public Health. The institute sponsors workshops and seminars featuring speakers from American Association for the Advancement of Science, educators from Carnegie Mellon University, and clinicians from Massachusetts General Hospital.
Funding sources combine federal grants from agencies such as the National Institutes of Health and the Agency for Healthcare Research and Quality, philanthropic gifts from foundations like the Gates Foundation and Burroughs Wellcome Fund, and industry partnerships with corporations including Roche and Bristol Myers Squibb. Strategic partnerships involve alliances with academic partners like University of North Carolina at Chapel Hill, international collaborators such as Imperial College London, and consortia that include members from European Molecular Biology Laboratory and Wellcome Trust.
Category:Duke University Category:Medical research institutes in the United States